Synthesis, Cytotoxicity, Antioxidant Activity, DFT Calculations, and Docking Studies of New Pyridine-Malonate Derivatives as Potential Anticancer Agents

References

• R.L. Siegel, K.D. Miller, and A. Jemal, “Cancer Statistics, 2015,” Cancer 65, no. 1 (2015): 5–29. doi:10.3322/caac.21254
   Web of Science ®Google Scholar
• N. Colombo, E. Preti, F. Landoni, S. Carinelli, A. Colombo, C. Marini, and C. Sessa, ESMO Guidelines Working Group. “Endometrial Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up,” Annals of Oncology24, no. Suppl 6 (2013): vi33–vi38. doi:10.1093/annonc/mdt353
   PubMed Web of Science ®Google Scholar
• M.M. Alam, “Synthesis and Anticancer Activity of Novel Eugenol Derivatives against Breast Cancer Cells,” Natural Product Research 37, no. 10 (2023): 1632–1640. doi:10.1080/14786419.2022.2103809
   PubMed Web of Science ®Google Scholar
• A.S.A. Almalki, S. Nazreen, S.E.I. Elbehairi, M. Asad, A.A. Shati, M.Y. Alfaifi, A. Alhadhrami, A.A. Elhenawy, A.Q. Alorabi, A.M. Asiri, et al. “Design, Synthesis, Anticancer Activity and Molecular Docking Studies of New Benzimidazole Derivatives Bearing 1,3,4-Oxadiazole Moieties as Potential Thymidylate Synthase Inhibitors,” New Journal of Chemistry 46, no. 31 (2022): 14967–14978. doi:10.1039/D2NJ01980A
   Web of Science ®Google Scholar
• S. Ahmed Saleh Alzahrani, S. Nazreen, A.A. Elhenawy, T. Neamatallah, and M. Mahboob, “Synthesis, Biological Evaluation, and Molecular Docking of New Benzimidazole-1,2,3-Triazole Hybrids as Antibacterial and Antitumor Agents,” Polycyclic Aromatic Compounds 43, no. 4 (2023): 3380–3391. doi:10.1080/10406638.2022.2069133
   Web of Science ®Google Scholar
• F.X. Ruiz, A. Hoang, K. Das, and E. Arnold, “Structural Basis of HIV-1 Inhibition by Nucleotide-Competing Reverse Transcriptase Inhibitor INDOPY-1,” Journal of Medicinal Chemistry 62, no. 21 (2019): 9996–10002. doi:10.1021/acs.jmedchem.9b01289
   PubMed Web of Science ®Google Scholar
• H.H. Sayed, E.M.H. Morsy, and E.M. Flefel, “Synthesis and Reactions of Some Novel Nicotinonitrile, Thiazolotriazole, and Imidazolotriazole Derivatives for Antioxidant Evaluation,” Synthetic Communications 40, no. 9 (2010): 1360–1370. doi:10.1080/00397910903079631
   Web of Science ®Google Scholar
• A.S. Girgis, N. Mishriky, M. Ellithey, H.M. Hosni, and H. Farag, “Novel Synthesis of [1]-Benzothiepino[5,4-b]Pyridine-3-Carbonitriles and Their anti-Inflammatory Properties,” Bioorganic & Medicinal Chemistry 15, no. 6 (2007): 2403–2413. doi:10.1016/j.bmc.2007.01.015
   PubMed Web of Science ®Google Scholar
• R.E. Khidre, A.A. Abu-Hashem, and M. El-Shazly, “Synthesis and anti-Microbial Activity of Some 1- Substituted Amino-4,6-Dimethyl-2-Oxo-Pyridine-3-Carbonitrile Derivatives,” European Journal of Medicinal Chemistry 46, no. 10 (2011): 5057–5064. doi:10.1016/j.ejmech.2011.08.018
   PubMed Web of Science ®Google Scholar
• N.A. Abdel-Latif, “Synthesis and Antidepressant Activity of Some New Coumarin Derivatives,” Scientia Pharmaceutica 73, no. 4 (2005): 193–216. doi:10.3797/scipharm.aut-05-15
   Google Scholar
• F. Hernández, A. Sánchez, P. Rendón-Vallejo, C. Millán-Pacheco, Y. Alcaraz, F. Delgado, M.A. Vázquez, and S. Estrada-Soto, “Synthesis, ex Vivo and in Silico Studies of 3-Cyano-2-Pyridone Derivatives with Vasorelaxant Activity,” European Journal of Medicinal Chemistry 70 (2013): 669–676. doi:10.1016/j.ejmech.2013.10.018
   PubMed Web of Science ®Google Scholar
• X. Wei, J. Yang, Z. Dai, H.-F. Yu, C.-F. Ding, A. Khan, Y.-L. Zhao, Y.-P. Liu, and X.-D. Luo, “Antitumor Pyridine Alkaloids Hybrid with Diverse Units from Alangium Chinense,” Tetrahedron Letters 61, no. 7 (2020): 151502. doi:10.1016/j.tetlet.2019.151502
   Web of Science ®Google Scholar
• A.T.A. Boraei, E.H. Eltamany, I.A.I. Ali, S.M. Gebriel, and M.S. Nafie, “Synthesis of New Substituted Pyridine Derivatives as Potent anti-Liver Cancer Agents through Apoptosis Induction: In Vitro, in Vivo, and in Silico Integrated Approaches,” Bioorganic Chemistry 111 (2021): 104877. doi:10.1016/j.bioorg.2021.104877
   PubMed Web of Science ®Google Scholar
• A.H. Abadi, D.A. Abouel-Ella, J. Lehmann, H.N. Tinsley, B.D. Gary, G.A. Piazza, and M.A.O. Abdel-Fattah, “Discovery of Colon Tumor Cell Growth Inhibitory Agents through a Combinatorial Approach,” European Journal of Medicinal Chemistry 45, no. 1 (2010): 90–97. doi:10.1016/j.ejmech.2009.09.029
   PubMed Web of Science ®Google Scholar
• H. Shinkai, S. Onogi, M. Tanaka, T. Shibata, M. Iwao, K. Wakitani, and I. Uchida, “Isoxazolidine-3,5-Dione and Noncyclic 1,3-Dicarbonyl Compounds as Hypoglycemic Agents,” Journal of Medicinal Chemistry 41, no. 11 (1998): 1927–1933. doi:10.1021/jm970771m
   PubMed Web of Science ®Google Scholar
• K. Serafin, P. Mazur, A. Bak, E. Laine, L. Tchertanov, J.-F. Mouscadet, and J. Polanski, “Ethyl Malonate Amides: A Diketo Acid Offspring Fragment for HIV Integrase Inhibition,” Bioorganic & Medicinal Chemistry 19, no. 16 (2011): 5000–5005. doi:10.1016/j.bmc.2011.06.054
   PubMed Web of Science ®Google Scholar
• S. Zhang, K. Cheng, X. Wang, and H. Yin, “Selection, Synthesis, and anti-Inflammatory Evaluation of the Arylidene Malonate Derivatives as TLR4 Signaling Inhibitors,” Bioorganic & Medicinal Chemistry 20, no. 20 (2012): 6073–6079. doi:10.1016/j.bmc.2012.08.022
   PubMed Web of Science ®Google Scholar
• J.-C. Su, Y.-T. Huang, C.-S. Chen, H.-C. Chiu, and C.-W.Shiau, “Design and Synthesis of Malonamide Derivatives as Antibiotics against Methicillin-Resistant Staphylococcus aureus,” Molecules 23, no. 1 (2017): 27. doi:10.3390/molecules23010027
   PubMed Web of Science ®Google Scholar
• R.F. Enes, A.S.F. Farinha, A.C. Tomé, J.A.S. Cavaleiro, R. Amorati, S. Petrucci, and G.F. Pedulli, “Synthesis and Antioxidant Activity of [60]Fullerene–Flavonoid Conjugates,” Tetrahedron 65, no. 1 (2009): 253–262. doi:10.1016/j.tet.2008.10.066
   Web of Science ®Google Scholar
• D. Grée, S. Vorin, V.L. Manthati, F. Caijo, G. Viault, F. Manero, P. Juin, and R. Grée, “The Synthesis of New, Selected Analogues of the Pro-Apoptotic and Anticancer Molecule HA 14-1,” Tetrahedron Letters 49, no. 20 (2008): 3276–3278. doi:10.1016/j.tetlet.2008.03.070
   Web of Science ®Google Scholar
• Z. Zhou, F. Chen, G. Xu, and S. Gou, “Study on the Cytotoxic Activity of Platinum(II) Complexes of (1R,2R)-N1-Cyclopentyl-1,2-Cyclohexanediamine with Substituted Malonate Derivatives,” Bioorganic & Medicinal Chemistry Letters 26, no. 2 (2016): 322–327. doi:10.1016/j.bmcl.2015.12.019
   PubMed Web of Science ®Google Scholar
• Z. Zebbiche, S. Tekin, H. Küçükbay, F. Yüksel, and B. Boumoud, “Synthesis and Anticancer Properties of Novel Hydrazone Derivatives Incorporating Pyridine and Isatin Moieties,” Archiv Der Pharmazie 354, no. 5 (2021): e2000377. doi:10.1002/ardp.202000377]
   PubMed Web of Science ®Google Scholar
• M.I. Chouiter, H. Boulebd, D.M. Pereira, P. Valentão, P.B. Andrade, A. Belfaitah, and A.M. Silva, “New Chalcone-Type Compounds and 2-Pyrazoline Derivatives: Synthesis and Caspase-Dependent Anticancer Activity,” Future Medicinal Chemistry 12, no. 6 (2020): 493–509. doi:10.4155/fmc-2019-0342
   PubMed Web of Science ®Google Scholar
• A.H. Abadi, T.M. Ibrahim, K.M. Abouzid, J. Lehmann, H.N. Tinsley, B.D. Gary, and G.A. Piazza, “Design, Synthesis and Biological Evaluation of Novel Pyridine Derivatives as Anticancer Agents and Phosphodiesterase 3 Inhibitors,” Bioorganic & Medicinal Chemistry 17, no. 16 (2009): 5974–5982. doi:10.1016/j.bmc.2009.06.063
   PubMed Web of Science ®Google Scholar
• H. Boulebd, “Structure-Activity Relationship of Antioxidant Prenylated (Iso)Flavonoid-Type Compounds: Quantum Chemistry and Molecular Docking Studies,” Journal of Biomolecular Structure & Dynamics 40, no. 20 (2022): 10373–10382. doi:10.1080/07391102.2021.1943529
   PubMed Web of Science ®Google Scholar
• H. Boulebd, “Insights on the Antiradical Capacity and Mechanism of Phytocannabinoids: H-Abstraction and Electron Transfer Processes in Physiological Media and the Influence of the Acid-Base Equilibrium,” Phytochemistry 208 (2023): 113608. doi:10.1016/j.phytochem.2023.113608
   PubMed Web of Science ®Google Scholar
• H. Boulebd, “Comparative Study of the Radical Scavenging Behavior of Ascorbic Acid, BHT, BHA and Trolox: Experimental and Theoretical Study,” Journal of Molecular Structure 1201 (2020): 127210. doi:10.1016/j.molstruc.2019.127210
   Web of Science ®Google Scholar
• P.K. Chattaraj, U. Sarkar, and D.R. Roy, “Electrophilicity Index,” Chemical Reviews 106, no. 6 (2006): 2065–2091. doi:10.1021/cr040109f
   PubMed Web of Science ®Google Scholar
• R.G. Parr, L.v Szentpály, and S. Liu, “Electrophilicity Index,” Journal of the American Chemical Society 121, no. 9 (1999): 1922–1924. doi:10.1021/ja983494x
   Web of Science ®Google Scholar
• R. Praveena, K. Sadasivam, V. Deepha, and R. Sivakumar, “Antioxidant Potential of Orientin: A Combined Experimental and DFT Approach,” Journal of Molecular Structure 1061 (2014): 114–123. doi:10.1016/j.molstruc.2014.01.002
   Web of Science ®Google Scholar
• R. Karki, C. Park, K.-Y. Jun, T.M. Kadayat, E.-S. Lee, and Y. Kwon, “Synthesis and Biological Activity of 2,4-di-p-Phenolyl-6-2-Furanyl-Pyridine as a Potent Topoisomerase II Poison,” European Journal of Medicinal Chemistry 90 (2015): 360–378. doi:10.1016/j.ejmech.2014.11.045
   PubMed Web of Science ®Google Scholar
• P. Thapa, R. Karki, U. Thapa, Y. Jahng, M.-J. Jung, J.M. Nam, Y. Na, Y. Kwon, and E.-S. Lee, “2-Thienyl-4-Furyl-6-Aryl Pyridine Derivatives: Synthesis, Topoisomerase I and II Inhibitory Activity, Cytotoxicity, and Structure–Activity Relationship Study,” Bioorganic & Medicinal Chemistry 18, no. 1 (2010): 377–386. doi:10.1016/j.bmc.2009.10.049
   PubMed Web of Science ®Google Scholar
• K.-Y. Jun, H. Kwon, S.-E. Park, E. Lee, R. Karki, P. Thapa, J.-H. Lee, E.-S. Lee, and Y. Kwon, “Discovery of Dihydroxylated 2,4-Diphenyl-6-Thiophen-2-yl-Pyridine as a Non-Intercalative DNA-Binding Topoisomerase II-Specific Catalytic Inhibitor,” European Journal of Medicinal Chemistry 80 (2014): 428–438. doi:10.1016/j.ejmech.2014.04.066
   PubMed Web of Science ®Google Scholar
• R. Karki, P. Thapa, H.Y. Yoo, T.M. Kadayat, P.-H. Park, Y. Na, E. Lee, K.-H. Jeon, W.-J. Cho, H. Choi, et al. “Dihydroxylated 2,4,6-Triphenyl Pyridines: Synthesis, Topoisomerase I and II Inhibitory Activity, Cytotoxicity, and Structure–Activity Relationship Study,” European Journal of Medicinal Chemistry 49 (2012): 219–228. doi:10.1016/j.ejmech.2012.01.015
   PubMed Web of Science ®Google Scholar
• C.-C. Wu, T.-K. Li, L. Farh, L.-Y. Lin, T.-S. Lin, Y.-J. Yu, T.-J. Yen, C.-W. Chiang, and N.-L. Chan, “Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide,” Science 333, no. 6041 (2011): 459–462. doi:10.1126/science.1204117
   PubMed Web of Science ®Google Scholar
• S. Reuter, S.C. Gupta, M.M. Chaturvedi, and B.B. Aggarwal, “Oxidative Stress, Inflammation, and Cancer: How Are They Linked?,” Free Radical Biology & Medicine 49, no. 11 (2010): 1603–1616. doi:10.1016/j.freeradbiomed.2010.09.006
   PubMed Web of Science ®Google Scholar
• Y.-O. Teng, H.-Y. Zhao, J. Wang, H. Liu, M.-L. Gao, Y. Zhou, K.-L. Han, Z.-C. Fan, Y.-M. Zhang, H. Sun, et al. “Synthesis and Anti-Cancer Activity Evaluation of 5-(2-Carboxyethenyl)-Isatin Derivatives,” European Journal of Medicinal Chemistry 112 (2016): 145–156. doi:10.1016/j.ejmech.2015.12.050
   PubMed Web of Science ®Google Scholar
• M.J. Frisch, G. Trucks, H.B. Schlegel, et al. Gaussian 09, Revision A. 1, vol. 27 (Wallingford, CT: Gaussian Inc., 2009), 34.
   Google Scholar
• A.D. Becke, “Density-Functional Exchange-Energy Approximation with Correct Asymptotic Behavior,” Physical Review-A, General Physics 38, no. 6 (1988): 3098–3100. doi:10.1103/physreva.38.3098
   PubMedGoogle Scholar
• P.C. Hariharan and J.A. Pople, “The Influence of Polarization Functions on Molecular Orbital Hydrogenation Energies,” Theoretica Chimica Acta 28, no. 3 (1973): 213–222. doi:10.1007/BF00533485
   Google Scholar
• W. Guerrab, H. Lgaz, S. Kansiz, J.T. Mague, N. Dege, M. Ansar, R. Marzouki, J. Taoufik, I.H. Ali, I.-M. Chung, et al. “Synthesis of a Novel Phenytoin Derivative: Crystal Structure, Hirshfeld Surface Analysis and DFT Calculations,” Journal of Molecular Structure 1205 (2020): 127630. doi:10.1016/j.molstruc.2019.127630
   Web of Science ®Google Scholar
• F. Ahmad, M. Parveen, M. Alam, S. Azaz, A.M. Malla, M.J. Alam, D.-U. Lee, and S. Ahmad, “Synthesis, X-Ray Crystallography, Spectroscopic (FT-IR, 1H &13C NMR and UV), Computational (DFT/B3LYP) and Enzymes Inhibitory Studies of 7-Hydroximinocholest-5-En-3-ol Acetate,” Journal of Molecular Structure 1116 (2016): 317–332. doi:10.1016/j.molstruc.2016.03.056
   Web of Science ®Google Scholar
• H. Boulebd, “DFT Study of the Antiradical Properties of Some Aromatic Compounds Derived from Antioxidant Essential Oils: C–H Bond vs. O–H Bond,” Free Radical Research 53, no. 11–12 (2019): 1125–1134. doi:10.1080/10715762.2019.1690652
   PubMed Web of Science ®Google Scholar
• H. Boulebd, Y.D. Lahneche, I.A. Khodja, M. Benslimane, and A. Belfaitah, “New Schiff Bases Derived from Benzimidazole as Efficient Mercury-Complexing Agents in Aqueous Medium,” Journal of Molecular Structure 1196 (2019): 58–65. doi:10.1016/j.molstruc.2019.06.060
   Web of Science ®Google Scholar
• O. Trott and A.J. Olson, “AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading,” Journal of Computational Chemistry 31, no. 2 (2010): 455–461. doi:10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar